Discovery of Potent and Selective Quinazoline-Based LATS1/2 Inhibitors Promoting Hepatic Regeneration
Therapeutic acceleration of endogenous liver regeneration remains a considerable unmet need for patients with acute or chronic liver injury. Among the pathways that coordinate regenerative responses, the Hippo pathway and its main components LATS1/2 kinases play a critical role by limiting YAP-dependent transcriptional programs associated with regeneration. Pharmacological inhibition of LATS1/2 thus represents a strategy to activate hepatic YAP signaling and promote tissue repair. Herein, we report the discovery of quinazoline-based LATS1/2 inhibitors derived from VT-02956 (1). Structure−activity relationship studies identified compound 24, a single-digit nanomolar LATS1/2 inhibitor with improved cellular YAP activation and metabolic stability. Compound 24 showed favorable kinase selectivity (S(35) = 0.04) and improved pharmacokinetics. In a partial hepatectomy mouse model, intraperitoneal administration of 24 activated YAP signaling, as evidenced by the upregulation of Cyr61 and Ankrd1, and significantly enhanced hepatocyte proliferation. These findings establish a medicinal chemistry foundation for developing LATS1/2 inhibitors as therapeutic agents for hepatic regeneration.
Authors
- Na Young Lee (ORCID: https://orcid.org/0000-0002-0808-9260)
- Byumseok Koh (ORCID: https://orcid.org/0000-0002-1106-1891)
- Ja Hyun Koo (ORCID: https://orcid.org/0000-0001-5738-1105)
- Nam‐Chul Cho (ORCID: https://orcid.org/0000-0002-6735-1302)
- Hongjun Jeon (ORCID: https://orcid.org/0000-0001-5153-5118)
- Seokwoo Lee (ORCID: https://orcid.org/0000-0002-8309-0624)
- Eui Jin Lee (ORCID: https://orcid.org/0000-0002-8371-8637)
- Anagha Reneesh
- 오예주
- Minji Kang
- Sunjoo Ahn
Institutions
- Seoul National University (KR)
- Chungnam National University (KR)
- Korea Research Institute of Chemical Technology (KR)
- Korea University of Science and Technology (KR)
Publication Details
- Journal
- Journal of Medicinal Chemistry
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1021/acs.jmedchem.6c01827
- Primary Topic
- Hippo pathway signaling and YAP/TAZ
- Type
- article
- Field-Weighted Citation Impact
- 0.00